Ignite Creation Date:
2025-12-26 @ 10:17 PM
Ignite Modification Date:
2026-03-09 @ 10:32 AM
Study NCT ID:
NCT06805812
Status:
RECRUITING
Last Update Posted:
2025-02-03
First Post:
2025-01-07
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Predicting clinicAL outcoMes During First-line CDK4/6 Inhibitors Plus Endocrine Therapy in Patients With Advanced Hormone REceptor-poSitive HER2-negative Breast Cancer: the Retrospective-prospective Multicenter Italian PALMARES-2 Study
Sponsor:
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-05-01
Start Date Type:
ACTUAL
Primary Completion Date:
2030-12-31
Primary Completion Date Type:
ESTIMATED
Completion Date:
2040-12-31
Completion Date Type:
ESTIMATED
First Submit Date:
2025-01-07
First Submit QC Date:
None
Study First Post Date:
2025-02-03
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-01-28
Last Update Post Date:
2025-02-03
Last Update Post Date Type:
ACTUAL